PQA

JULY 28, 2023

Transforming Pharmacy Care Beyond the Pandemic Walgreens' Rina Shah discusses how the retail pharmacy segment has changed since the start of COVID-19 and what the future of treatment and vaccines for the virus looks like as regulations begin to change. If you would like to support this important effort, contact us at QuIRC@PQAalliance.org.

Documentation 40

Documentation Vaccines 40

PQA

JUNE 16, 2023

Additional medical services beyond vaccinations are becoming more routine at pharmacies. PQA's 3rd Quarter 2023 Stakeholder Advisory Meeting is August 2, 1-1:30 pm ET. Save the Date for the PQA Convenes: Advancing the Quality of Medication Therapy Management and the 2023 PQA Leadership Summit, November 2-3, 2023 in Arlington, Va.

Documentation 40

Documentation Vaccines 40

The FDA Law Blog

JANUARY 7, 2024

To better understand FDA’s approach in classifying postmarketing pregnancy studies as PMRs or PMCs, we reviewed all postmarketing requirements (PMRs) and postmarketing commitments (PMCs) related to maternal and fetal outcomes in FDA’s PMR/PMC database for drugs approved in the ten-year period from January 2014 through December 2023.

FDA 59

FDA Documentation Vaccines 59

The FDA Law Blog

SEPTEMBER 30, 2024

Gaulkin — In May 2023, we posted about a CMS proposed regulation that sought to make a wide variety of changes to the Medicaid Drug Rebate Program (MDRP), including a new “price verification survey,” and a controversial proposal to require “stacking” of discounts to different customers when determining best price.

Vaccines 59

Vaccines Packaging FDA Documentation 59

The Checkup by Singlecare

OCTOBER 10, 2023

As of March 2023, more than 5.8 Required documents for application When applying for Medicaid in Texas, you should have all relevant information readily available and be prepared to provide documentation if requested. By coming prepared with your paperwork, you can save time and get your application processed quicker.

Insurance 52

Insurance Insurance Coverage Documentation Hospitals 52

pharmaphorum

JANUARY 9, 2023

This Nine for 2023 three-part series will argue that, this year, the future-facing Janus prediction of unprecedented and transformative change is true. However, the pandemic is only one of the often deep-rooted forces that will come together in 2023 to exert transformative pressure on healthcare.

Vaccines 98

Vaccines Pharmaceutical Companies Pharmaceutical Companies Documentation 98

ISPE

SEPTEMBER 8, 2023

2023 ISPE Aseptic Conference Regulatory Panel Logan Thomas Fri, 09/08/2023 - 11:35 InTouch September / October 2023 2023 ISPE Aseptic Conference Regulatory Panel Jörg Zimmermann 1 September 2023 On 7 March 2023, ISPE concluded the 2023 ISPE Aseptic Conference with a regulatory panel question and answer session.

FDA 52

FDA Vaccines Documentation 52

European Pharmaceutical Review

NOVEMBER 9, 2022

Within recent years this situation has been further exacerbated by the COVID-19 pandemic: both directly, through viral vaccine manufacture; and indirectly, through instability in global supply chains. Those available commercially include adenoviral-based vaccines by AstraZeneca and Johnson & Johnson.

Vaccines 115

Vaccines Documentation Communication Hospitals 115

pharmaphorum

NOVEMBER 24, 2021

The pandemic has propelled issues for the pharmaceutical industry to the top of the political and public agenda, from clinical trial recruitment to the journey required for medicines or vaccines to reach patients. Getting the UK’s COVID vaccine and treatments programme ahead of schedule. Why is this important for the UK?

Vaccines 98

Vaccines Documentation 98

ISPE

OCTOBER 27, 2022

It is a great honour and pleasure for me as the 2022-2023 ISPE Board Past Chair and Chair of the 2023 ISPE Aseptic Conference Program Committee to give you a first glimpse at the program and of the information and knowledge that will be shared at the conference. SARS CoV-2 vaccines have been formulated in lipid nanoparticles.

Dosage 98

Dosage Vaccines FDA Documentation 98

pharmaphorum

JULY 12, 2021

Madden said: “The data have helped us to first identify, and then protect, those most at risk from the virus itself, and it’s proven the efficacy and the safety of our world leading vaccination programme.”. Proposals: Data infrastructure. The pandemic has offered up opportunities that “we cannot look away from”, he went on.

Documentation 75

Documentation Vaccines 75

Pharmaceutical Technology

NOVEMBER 3, 2022

The Australian Department of Health and Aged Care published a similar statement on August 25, stating that tenecteplase shortages will likely affect the country until the end of 2023. After all, there have been united efforts before, pointing to the EU-wide Covid-19 vaccine procurement strategy as a good example, he says.

Documentation 111

Documentation Dosage Vaccines Hospitals 111

ISPE

SEPTEMBER 11, 2023

Considerations for a Decentralized Manufacturing Paradigm Trudy Patterson Mon, 09/11/2023 - 06:47 Features September / October 2023 Considerations for a Decentralized Manufacturing Paradigm Marquerita Algorri, PhD Ting Wang, PhD Jocelyn X. 7 June 2023. New Project: Evolutive Vaccines Facility for Sanofi.” McQueen Nina S.

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

Pharmaceutical Technology

FEBRUARY 1, 2023

Pharmaceutical companies have been working on developing vaccines and other prophylactics for respiratory syncytial virus (RSV) since its discovery in 1956. Despite strong efforts and scientific advances, a safe and effective vaccine for RSV has yet to be approved for any patient population.

Vaccines 64

Vaccines Documentation Pharmaceutical Companies Pharmaceutical Companies 64

Pharmaceutical Technology

APRIL 27, 2023

The successful development and deployment of the mRNA-based COVID-19 vaccines has catalysed the biopharma industry and paved the way to expand this drug modality to new therapeutic areas. Excluding vaccines, there are five mRNA therapeutic products in clinical trial development as of November 2022. billion by 2028.

Vaccines 52

Vaccines Documentation Communication 52

Pharmaceutical Technology

MAY 5, 2023

The value of real-time data Amid unprecedented instability in lockdown-stricken supply chains, digital transformation company Controlant helped to safely deliver more than 5 billion COVID-19 vaccines. Another important thing is that manual evaluations have been reduced to less than 0.5%

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 59

STAT

MARCH 4, 2025

But in a court document filed on Sept. In 2023, one judge in Alberta, Canada, wrote that, as an expert witness, Bhattacharya was unwilling to accept inconvenient facts and “advancing a personal agenda.” They’d gone back and forth, first by Twitter message, then by email, and eventually, on Sept.

Documentation 142

Documentation Vaccines 142

The Thyroid Pharmacist

NOVEMBER 8, 2024

A new test is being developed for MAP detection in support of a vaccine for Crohn’s disease; it has been in clinical trials, and looks very promising. Researchers found they could suppress the autoimmune response if using a vaccine or antibiotic that specifically eradicates E. Published 2023 Mar 16. gallinarum. [55] Tumour Biol.

Immunization 72

Immunization Adverse Reactions Vaccines Hospitals 72